{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T09:15:17Z","timestamp":1725182117442},"reference-count":70,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2013.0167","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:25:18Z","timestamp":1525253118000},"source":"Crossref","is-referenced-by-count":3,"title":["Irreversible Liver Failure"],"prefix":"10.3238","author":[{"given":"Andreas","family":"Pascher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Nebrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"10.3238\/arztebl.2013.0167_ref1","unstructured":"Deutsche Stiftung Organtransplantation: Funktionsraten nach Lebertransplantation. www.dso.de\/medien-und-presse\/pressebilder-und-grafiken.html. Last accessed on 20 February 2013."},{"key":"10.3238\/arztebl.2013.0167_ref2","unstructured":"Schmidt, H: Lebertransplantation: Eine faire Chance f\u00fcr jeden. Dtsch Arztebl 2007; 104(34\u201335): A-2324."},{"key":"10.3238\/arztebl.2013.0167_ref3","unstructured":"Rahmel A, Osterlee A, Eurotransplant International Foundation \u2013 Annual Report 2007."},{"key":"10.3238\/arztebl.2013.0167_ref4","doi-asserted-by":"crossref","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864\u201371.","DOI":"10.1053\/he.2000.5852"},{"key":"10.3238\/arztebl.2013.0167_ref5","unstructured":"Bundes\u00e4rztekammer: Richtlinien zur Organtransplantation gem\u00e4\u00df \u00a7 16 Abs. 1. Dtsch Arztebl 2010; 107: A 1532\u201341."},{"key":"10.3238\/arztebl.2013.0167_ref6","doi-asserted-by":"crossref","unstructured":"Schmeding M, Heidenhain C, Neuhaus R, Neuhaus P, Neumann UP: Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Dig Dis Sci 2011; 56: 236\u201343.","DOI":"10.1007\/s10620-010-1281-7"},{"key":"10.3238\/arztebl.2013.0167_ref7","unstructured":"Hartl J, Scherer MN, Loss M, et al.: Strong predictors for alcohol recidivism after liver transplantation: non-acceptance of the alcohol problem and abstinence of"},{"key":"10.3238\/arztebl.2013.0167_ref8","doi-asserted-by":"crossref","unstructured":"Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER: Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004; 10: 968\u201374.","DOI":"10.1002\/lt.20217"},{"key":"10.3238\/arztebl.2013.0167_ref9","doi-asserted-by":"crossref","unstructured":"Rosenau J, Hooman N, Hadem J, et al.: Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007; 13: 367\u201373.","DOI":"10.1002\/lt.21003"},{"key":"10.3238\/arztebl.2013.0167_ref10","doi-asserted-by":"crossref","unstructured":"Cholongitas E, Papatheodoridis GV, et al.: Hepatitis B immunoglobulin and\/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review. Liver Transpl 2011; 17: 1176\u201390.","DOI":"10.1002\/lt.22354"},{"key":"10.3238\/arztebl.2013.0167_ref11","doi-asserted-by":"crossref","unstructured":"Gane EJ, Portmann BC, Naoumov NV, et al.: Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815\u201320.","DOI":"10.1056\/NEJM199603283341302"},{"key":"10.3238\/arztebl.2013.0167_ref12","doi-asserted-by":"crossref","unstructured":"Neuberger J: Treatment of hepatitis C virus infection in the allograft. Liver Transpl 2003; 9: 101\u20138.","DOI":"10.1053\/jlts.2003.50250"},{"key":"10.3238\/arztebl.2013.0167_ref13","doi-asserted-by":"crossref","unstructured":"Mutimer DJ, Gunson B, Chen J, et al.: Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006; 81: 7\u201314.","DOI":"10.1097\/01.tp.0000188619.30677.84"},{"key":"10.3238\/arztebl.2013.0167_ref14","doi-asserted-by":"crossref","unstructured":"Wali M, Harrison RF, Gow PJ, Mutimer D, et al.: Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248\u201352.","DOI":"10.1136\/gut.51.2.248"},{"key":"10.3238\/arztebl.2013.0167_ref15","doi-asserted-by":"crossref","unstructured":"Vogel A, Heinrich E, Bahr MJ, et al.: Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004; 18: 62\u20139.","DOI":"10.1111\/j.1399-0012.2004.00117.x"},{"key":"10.3238\/arztebl.2013.0167_ref16","doi-asserted-by":"crossref","unstructured":"Wiencke K, Boberg KM: Current consensus on the management of primary sclerosing cholangitis. Clin Res Hepatol Gstroenterol 2011; 35: 786\u201391.","DOI":"10.1016\/j.clinre.2011.04.007"},{"key":"10.3238\/arztebl.2013.0167_ref17","doi-asserted-by":"crossref","unstructured":"Alabraba E, Nightingale P, Gunson B, et al.: A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009; 15: 330\u201340.","DOI":"10.1002\/lt.21679"},{"key":"10.3238\/arztebl.2013.0167_ref18","doi-asserted-by":"crossref","unstructured":"Milkiewicz P: Liver transplantation in primary biliary cirrhosis. Clin Liver Dis 2008; 12: 461\u201372xi.","DOI":"10.1016\/j.cld.2008.02.015"},{"key":"10.3238\/arztebl.2013.0167_ref19","doi-asserted-by":"crossref","unstructured":"Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693\u20139.","DOI":"10.1056\/NEJM199603143341104"},{"key":"10.3238\/arztebl.2013.0167_ref20","doi-asserted-by":"crossref","unstructured":"Jonas S, Al-Abadi H, Benckert C, et al.: Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 2009; 250: 1008\u201313.","DOI":"10.1097\/SLA.0b013e3181b2b195"},{"key":"10.3238\/arztebl.2013.0167_ref21","doi-asserted-by":"crossref","unstructured":"Jonas S, Bechstein WO, Steinm\u00fcller T, et al.: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080\u20136.","DOI":"10.1053\/jhep.2001.23561"},{"key":"10.3238\/arztebl.2013.0167_ref22","doi-asserted-by":"crossref","unstructured":"Mazzaferro V, Bhoori S, Sposito C, et al.: Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011; 17(Suppl 2): 44\u201357.","DOI":"10.1002\/lt.22365"},{"key":"10.3238\/arztebl.2013.0167_ref23","doi-asserted-by":"crossref","unstructured":"Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP: Acute liver failure: a life-threatening disease. Dtsch Arztebl Int 2011; 108: 714\u201320.","DOI":"10.3238\/arztebl.2011.0714"},{"key":"10.3238\/arztebl.2013.0167_ref24","doi-asserted-by":"crossref","unstructured":"Germani G, Theocharidou E, Adam R, et al.: Liver transplantation for acute liver failure in Europe: Outcomes over 20 years from the ELTR database. J Hepatol 2012; 57: 288\u201396.","DOI":"10.1016\/j.jhep.2012.03.017"},{"key":"10.3238\/arztebl.2013.0167_ref25","unstructured":"Hesse A, Waage P: Organ Donation and Transplantation in Germany, Annual Report 2011, DSO; 2012."},{"key":"10.3238\/arztebl.2013.0167_ref26","unstructured":"Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR): OPTN\/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011."},{"key":"10.3238\/arztebl.2013.0167_ref27","doi-asserted-by":"crossref","unstructured":"Wiesner RH, Demetris AJ, Belle SH, et al.: Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638\u201345.","DOI":"10.1002\/hep.510280306"},{"key":"10.3238\/arztebl.2013.0167_ref28","doi-asserted-by":"crossref","unstructured":"Adams DH, Neuberger JM: Treatment of acute rejection. Semin Liver Dis 1992; 12: 80\u20138.","DOI":"10.1055\/s-2007-1007379"},{"key":"10.3238\/arztebl.2013.0167_ref29","unstructured":"Centre for evidence in transplantation. www.esot.org\/Content.aspx?item=177. Last accessed on 10 December 2012."},{"key":"10.3238\/arztebl.2013.0167_ref30","doi-asserted-by":"crossref","unstructured":"McAlister VC, Haddad E, Renouf E, et al.: Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 2006; 6: 1578\u201385.","DOI":"10.1111\/j.1600-6143.2006.01360.x"},{"key":"10.3238\/arztebl.2013.0167_ref31","doi-asserted-by":"crossref","unstructured":"Haddad EM, McAlister VC, Renouf E, et al.: Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006; CD005161.","DOI":"10.1002\/14651858.CD005161.pub2"},{"key":"10.3238\/arztebl.2013.0167_ref32","doi-asserted-by":"crossref","unstructured":"Eason JD, Loss GE, Blazek J, et al.: Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl 2001; 7: 693\u20137.","DOI":"10.1053\/jlts.2001.26353"},{"key":"10.3238\/arztebl.2013.0167_ref33","doi-asserted-by":"crossref","unstructured":"Goralczyk AD, Hauke N, Bari N, et al.: Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies. Hepatology 2011; 54: 541\u201354.","DOI":"10.1002\/hep.24385"},{"key":"10.3238\/arztebl.2013.0167_ref34","doi-asserted-by":"crossref","unstructured":"Sgourakis G, Radtke A, Fouzas I, et al.: Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes. Transpl Int 2009; 22: 892\u2013905.","DOI":"10.1111\/j.1432-2277.2009.00893.x"},{"key":"10.3238\/arztebl.2013.0167_ref35","doi-asserted-by":"crossref","unstructured":"Segev DL, Sozio SM, Shin EJ, et al.: Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl 2008; 14: 512\u201325.","DOI":"10.1002\/lt.21396"},{"key":"10.3238\/arztebl.2013.0167_ref36","unstructured":"European liver transplant registry results. www.eltr.org\/: Last accessed on 23 December 2012."},{"key":"10.3238\/arztebl.2013.0167_ref37","doi-asserted-by":"crossref","unstructured":"Schlitt HJ, Loss M, Scherer MN, et al.: Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Z Gastroenterol 2011; 49: 30\u20138.","DOI":"10.1055\/s-0029-1245946"},{"key":"10.3238\/arztebl.2013.0167_ref38","doi-asserted-by":"crossref","unstructured":"Weismuller TJ, et al.: The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transpl Int 2009; 22: 970\u20138.","DOI":"10.1111\/j.1432-2277.2009.00915.x"},{"key":"10.3238\/arztebl.2013.0167_ref39","unstructured":"Aqua-Bundesauswertung zum Verfahrensjahr 2010 \u2013 Lebertransplantation; http:\/\/sqg.de\/downloads\/Bundesauswertungen\/2010\/bu_Gesamt_LTX_2010.pdf."},{"key":"10.3238\/arztebl.2013.0167_ref40","doi-asserted-by":"crossref","unstructured":"Mathurin P, Moreno C, Samuel D, et al.: Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365: 1790\u2013800.","DOI":"10.1056\/NEJMoa1105703"},{"key":"10.3238\/arztebl.2013.0167_ref41","doi-asserted-by":"crossref","unstructured":"Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, N\u00fcssler NC: Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007; 13: 197\u2013205.","DOI":"10.1002\/lt.20934"},{"key":"10.3238\/arztebl.2013.0167_ref42","doi-asserted-by":"crossref","unstructured":"Weism\u00fcller TJ, Prokein J, Becker T, et al.: Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008; 43: 736\u201346.","DOI":"10.1080\/00365520801932944"},{"key":"10.3238\/arztebl.2013.0167_ref43","doi-asserted-by":"crossref","unstructured":"Hughes SA, Wedemeyer H, Harrison PM: Hepatitis delta virus. Lancet 2011; 378: 73\u201385.","DOI":"10.1016\/S0140-6736(10)61931-9"},{"key":"10.3238\/arztebl.2013.0167_ref44","doi-asserted-by":"crossref","unstructured":"Ruemmele P, Hofstaedter F, Gelbmann CM: Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6: 287\u201395.","DOI":"10.1038\/nrgastro.2009.46"},{"key":"10.3238\/arztebl.2013.0167_ref45","doi-asserted-by":"crossref","unstructured":"van Keimpema L, Nevens F, Adam R, et al.: Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int 2011; 24: 1239\u201345.","DOI":"10.1111\/j.1432-2277.2011.01360.x"},{"key":"10.3238\/arztebl.2013.0167_ref46","doi-asserted-by":"crossref","unstructured":"Pinson CW, Moore DE: Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 2003; 5: 203\u20135.","DOI":"10.1080\/13651820310019938"},{"key":"10.3238\/arztebl.2013.0167_ref47","doi-asserted-by":"crossref","unstructured":"Grotz TE, Nagorney D, Donohue J, et al.: Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford) 2010; 12: 546\u201353.","DOI":"10.1111\/j.1477-2574.2010.00213.x"},{"key":"10.3238\/arztebl.2013.0167_ref48","doi-asserted-by":"crossref","unstructured":"Heimbach JK, Gores GJ, Haddock MG, et al.: Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24: 201\u20137.","DOI":"10.1055\/s-2004-828896"},{"key":"10.3238\/arztebl.2013.0167_ref49","doi-asserted-by":"crossref","unstructured":"Darwish Murad S, Kim WR, Harnois DM, et al.: Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers. Gastroenterology 2012; 143: 88\u201398.","DOI":"10.1053\/j.gastro.2012.04.008"},{"key":"10.3238\/arztebl.2013.0167_ref50","doi-asserted-by":"crossref","unstructured":"Canbay A, Jochum C, Bechmann LP, et al.: Acute liver failure in a metropolitan area in Germany: a retrospective study (2002\u20132008). Z Gastroenterol 2009; 47: 807\u201313.","DOI":"10.1055\/s-0028-1109058"},{"key":"10.3238\/arztebl.2013.0167_ref51","doi-asserted-by":"crossref","unstructured":"Ramirez CB, Doria C, di Francesco F, et al.: Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. J Surg Res 2007; 138: 198\u2013204.","DOI":"10.1016\/j.jss.2006.08.025"},{"key":"10.3238\/arztebl.2013.0167_ref52","doi-asserted-by":"crossref","unstructured":"Magrin S, Craxi A, Fabiano C, et al.: Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 1994; 19: 273\u20139.","DOI":"10.1002\/hep.1840190203"},{"key":"10.3238\/arztebl.2013.0167_ref53","doi-asserted-by":"crossref","unstructured":"Fong TL, Valinluck B, Govindarajan S, et al.: Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196\u20139.","DOI":"10.1016\/0016-5085(94)90077-9"},{"key":"10.3238\/arztebl.2013.0167_ref54","doi-asserted-by":"crossref","unstructured":"Liang W, Wang D, Ling X, et al.: Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl 2012; 18: 62\u20139.","DOI":"10.1002\/lt.22441"},{"key":"10.3238\/arztebl.2013.0167_ref55","unstructured":"Beckebaum S, Cicinnati V, Brokalaki E, et al.: CNI-sparing regimens within the liver transplant setting: experiences of a single center. Clin Transpl 2004; 215\u201320."},{"key":"10.3238\/arztebl.2013.0167_ref56","doi-asserted-by":"crossref","unstructured":"Watson CJ, Gimson AE, Alexander GJ, et al.: A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007; 13: 1694\u2013702.","DOI":"10.1002\/lt.21314"},{"key":"10.3238\/arztebl.2013.0167_ref57","doi-asserted-by":"crossref","unstructured":"Gomez-Camarero J, Salcedo M, Rincon D, et al.: Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms. Transplantation 2007; 84: 786\u201391.","DOI":"10.1097\/01.tp.0000280549.93403.dd"},{"key":"10.3238\/arztebl.2013.0167_ref58","doi-asserted-by":"crossref","unstructured":"Levitsky J: Operational tolerance: past lessons and future prospects. Liver Transpl 2011; 17: 222\u201332.","DOI":"10.1002\/lt.22265"},{"key":"10.3238\/arztebl.2013.0167_ref59","doi-asserted-by":"crossref","unstructured":"Bohne F, Mart\u00ednez-Llordella M, Lozano J, et al.: Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368\u201382.","DOI":"10.1172\/JCI59411"},{"key":"10.3238\/arztebl.2013.0167_ref60","doi-asserted-by":"crossref","unstructured":"Penninga L, Wettergren A, Chan AW, et al.: Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. Cochrane Database Syst Rev 2012; 3: CD008852.","DOI":"10.1002\/14651858.CD008852.pub2"},{"key":"10.3238\/arztebl.2013.0167_ref61","doi-asserted-by":"crossref","unstructured":"Treem WR: Liver transplantation for non-hepatotoxic inborn errors of metabolism. Curr Gastroenterol Rep 2006; 8: 215\u201323.","DOI":"10.1007\/s11894-006-0078-5"},{"key":"10.3238\/arztebl.2013.0167_ref62","unstructured":"www.eurotransplant.org\/cms\/index.php?page=annual_reports. Annual report 2011. Last accessed on 23 December 2012."},{"key":"10.3238\/arztebl.2013.0167_ref63","doi-asserted-by":"crossref","unstructured":"Pascher A, Neuhaus P: Bile duct complications after liver transplantation. Transpl Int 2005; 18: 627\u201342.","DOI":"10.1111\/j.1432-2277.2005.00123.x"},{"key":"10.3238\/arztebl.2013.0167_ref64","doi-asserted-by":"crossref","unstructured":"Bekker J, Ploem S, de Jong KP: Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 2009; 9: 746\u201357.","DOI":"10.1111\/j.1600-6143.2008.02541.x"},{"key":"10.3238\/arztebl.2013.0167_ref65","doi-asserted-by":"crossref","unstructured":"Bachir NM, Larson AM: Adult liver transplantation in the United States. Am J Med Sci 2012; 343: 462\u201369.","DOI":"10.1097\/MAJ.0b013e3182308b66"},{"key":"10.3238\/arztebl.2013.0167_ref66","doi-asserted-by":"crossref","unstructured":"Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR: Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420\u20137.","DOI":"10.1111\/j.1600-6143.2010.03126.x"},{"key":"10.3238\/arztebl.2013.0167_ref67","doi-asserted-by":"crossref","unstructured":"Weber ML, Ibrahim HN, Lake JR: Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl 2012; 18: 1290\u2013301.","DOI":"10.1002\/lt.23522"},{"key":"10.3238\/arztebl.2013.0167_ref68","doi-asserted-by":"crossref","unstructured":"Bodro M, Sab\u00e9 N, Llad\u00f3 L, et al.: Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients. Liver Transpl 2012; 18: 1093\u20139.","DOI":"10.1002\/lt.23460"},{"key":"10.3238\/arztebl.2013.0167_ref69","doi-asserted-by":"crossref","unstructured":"Pappas PG, Alexander BD, Andes DR, et al.: Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network. Clin Infect Dis 2010; 50: 1101\u201311.","DOI":"10.1086\/651262"},{"key":"10.3238\/arztebl.2013.0167_ref70","doi-asserted-by":"crossref","unstructured":"o\u2019Grady J: Livertransplantation for acute liver failure. Best Pract Res Clin Gastroenterol 2012; 26 : 27\u201333.","DOI":"10.1016\/j.bpg.2012.01.012"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:31:50Z","timestamp":1638797510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,8]]},"references-count":70,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2013.0167","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,8]]}}}